Money Matters Episode 349: The Battle for Cancer Research Funding w/ Dr. Fumiko Chino

Could cuts to federal cancer research funding slow new treatments, disrupt clinical trials, and affect the care patients receive years from now? In Money Matters Episode 349, Christopher Hensley speaks with Dr. Fumiko Chino, MD, FASCO, Associate Professor in Breast Radiation Oncology at The University of Texas MD Anderson Cancer Center. Dr. Chino explains how federally funded research reaches patients, why sustained investment through the NIH and National Cancer Institute matters, and how interruptions today could affect tomorrow's breakthroughs. In this episode, they discuss: • How federal research funding supports advances in cancer screening, treatment, and survivorship • What funding uncertainty can mean for researchers, clinical trials, and patients • How health-care affordability, medical debt, and financial toxicity affect patients and families • Why rural and underserved communities may face greater barriers to cutting-edge care • Why cancer research should be viewed as a long-term investment in health and economic well-being Dr. Chino also shares how personal loss helped shape her mission to improve cancer care, access, quality, affordability, and patients' lived experience. Learn more: Protect federal cancer research — ASCO Save Research https://www.asco.org/get-involved/advocacy/advocacy-agenda-initiatives/federally-funded-cancer-research/save-research Dr. Fumiko Chino — MD Anderson Cancer Center https://faculty.mdanderson.org/profiles/fumiko_chino.html This interview opportunity was provided by the Association for Clinical Oncology. Money Matters is provided for educational purposes only and is not individualized medical, legal, tax, or financial advice.